In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
Br J Cancer
; 129(1): 163-174, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37120667
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Carcinoma
/
Cystadenocarcinoma, Serous
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Br J Cancer
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: